About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01423071

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life

The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in ...

Lead sponsor: Wissenschaftliches Institut Bethanien e.V•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Wissenschaftliches Institut Bethanien e.V

Collaborators

Actelion Pharmaceuticals Deutschland GmbH

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age ≥ 18 years
•Known or newly diagnosed COPD or PAH
•Written informed consent
•Present long-term oxygen treatment is no exclusion criterion

Exclusion Criteria

•Age \< 18 years
•Right-heart catheterization not reasonable
•Pregnancy, Lactation
•Life expectancy \<12 months due to any diseases aside from COPD
•Any medical, psychological or other condition, which limits the patient's ability to provide informed consent
•No written informed consent provided
•Current participation in another clinical trial

Related studies

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

NCT06712563 · Pulmonary Disease, Chronic Obstructive

Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease

NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)

RECRUITINGPhase 2

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

NCT06814145 · Hypertension, Pulmonary

A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension

NCT07079592 · Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis, and more

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

NCT05719415 · Hypertension, Pulmonary, Pulmonary Thromboembolisms

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 18, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment220

Start dateAug 2011

Last updatedJun 18, 2015

Condition

Hypertension, Pulmonary Pulmonary Disease, Chronic Obstructive

Locations shown

Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Institute for Pneumology at the University Witten/Herdecke

Solingen, North Rhine-Westphalia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions